The AUC of PSA (4–10 ng/ml) for differentiating between PCa and BPH was 0.708, with a sensitivity of 0.837 and specificity of 0.583 (17); thus, screening based on PSA can lead to overdiagnosis and overtreatment (18). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.